CMG Pharmaceutical lowers conversion price to ₩17,290 on share price decline

CMG Pharmaceutical · KOSDAQ · 058820 · Nov 11, 2026 · Conversion price adjustments

CMG Pharmaceutical adjusted its conversion price from ₩17,770 to ₩17,290, effective Nov 11, 2026, citing a conversion price adjustment due to share price decline. The number of shares issuable on conversion rose from 422,172 shares to 433,892 shares.

Key facts

Price before adjustment₩17,770
Price after adjustment₩17,290
Shares before adjustment422,172 shares
Shares after adjustment433,892 shares
ReasonConversion price adjustment due to share price decline
Effective dateNov 11, 2026
Increase in shares issuable (calculated)2.8%

Comparison

Revenue 2025₩105.2bn
Revenue 2024₩99.1bn
Revenue 2023₩93.9bn

Context

In the 12 months before this filing, the company recorded 1 CB/BW/EB issuance of ₩45.0bn and 1 conversion price adjustment, with potential new shares of 48,277,149 shares, equal to 32.6% of shares.

Key metrics

Potential dilution

CB/BW/EB issued, last 12 months₩45.0bn As of Jun 30, 2026 Source 1 ↗
Rights offering new shares, last 12 months0 shares As of Nov 19, 2026
Potential new shares, last 12 months48,288,869 shares As of Nov 11, 2026 Source 1 ↗, Source 2 ↗, Source 3
Potential new shares, % of shares32.6% As of Nov 11, 2026 Source 1 ↗, Source 2 ↗, Source 3, Source 4 ↗
Conversion price adjustments, last 12 months2 As of Nov 11, 2026 Source 1 ↗, Source 2

Source: DART (Financial Supervisory Service) · Original filing on DART ↗ (opens the Financial Supervisory Service's DART site)